Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7306627
Acellular matrix grafts of collagen and elastic fiber
granted patentUS 7300774
Multimeric fusion proteins of the TNF superfamily ligands
granted patentUS 7300920
Antiangiogenic peptide agents
granted patentUS 7300915
Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
granted patentUS 7300660
Abundant extracellular products and methods for their production and use
granted patentUS 7294496
Cloned human lysophospholipase
granted patentUS 7288671
Interleukin-1 and tumor necrosis factor-Ξ± modulators, synthesis of said modulators and the
granted patentUS 7285527
Tumor radiosensitization using gene therapy
granted patentUS 7285534
Corticotropin-releasing hormone analogs and their uses
granted patentUS 7285415
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment o
granted patentUS 7282563
Opioid receptors and methods of use
granted patentUS 7282482
NGF for the prevention of demyelination in the nervous system
granted patentUS 7276643
Transgenic animals, cell lines derived therefrom, and methods for screening for anti-amylo
granted patentUS 7276352
Induction of Ξ² cell differentiation in human cells by stimulation of the GLP-1 receptor
granted patentUS 7273713
Methods of modulating mitochondrial NAD-dependent deacetylase
granted patentUS 7267978
Chimeric transcriptional regulatory element compositions and methods for increasing prosta
granted patentUS 7264820
Cancer immunotherapy using autologous tumor cells combined with cells expressing a membran
granted patentUS 7265208
Fusion molecules and treatment of IgE-mediated allergic diseases
granted patentUS 7265091
Methods and compositions for treating male erectile dysfunction
granted patentUS 7264816
Virulent systemic feline calicivirus
granted patentUS 7259236
RBP1L1, a novel retinoblastoma binding protein-related gene encoding an antigenic epitope
granted patentUS 7255850
Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-
granted patentUS 7256171
Use of core 2 G1cNAc transferase inhibitors in treating inflammation
granted patentUS 7253275
Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamy
granted